Pharmaceuticals News
|
The medical and pharmaceutical sectors are facing disruption from companies that occupy space traditionally outside of healthcare. These are companies like Apple and Google, plus an array of startups. What does this mean for the healthcare landscape?
|
|
A number of pharmaceutical companies are embracing connected technology with a bid to improve efficiencies and to reduce costs. This digital transformation of the sector includes smart factories and connected plants.
|
|
Ginkgo Bioworks, a startup known for its work turning bacteria into consumer goods, is partnering with marijuana producer Cronos to make lab-grown cannabis.
|
|
Salt Lake City -
On Thursday, seven health care systems and three philanthropic groups announced the formation of their own generic drug company, Civica Rx, to tackle chronic shortages and high prices.
|
|
Contract manufacturing organizations are on the leading edge of new pharmaceutical manufacturing technology adoption, according to a new overview of the sector.
|
|
London -
A number of British business are getting nervous about the Brexit process. Airbus, BMW and Siemens have each warned about the impact on their U.K.-based operations if the U.K. leaves the EU in March 2019 without any agreement.
|
|
Russia is the latest country to threaten retaliation against U.S. tariffs imposed on steel and aluminum imports, warning on Friday that American cars could soon face higher taxes.
|
|
Portmarnock -
The manufacture of pharmaceuticals, and an evaluation of microbial hazards, requires a scientific approach to risk assessment. This was the key message from the recent Pharmig meeting on Quality Risk Management.
|
|
Amazon Business, which is the bulk products arm of Amazon, appears to be dropping its plan to become a major distributor of pharmaceutical and medical devices products. This follows on from indications last year that Amazon was to enter the fray.
|
|
The drive for new medications addresses patient need and is the motor that keeps the pharmaceutical sector turning. To accelerate the drug discovery process, pharmaceutical organizations are turning to artificial intelligence.
|
New York City -
The company famous for its social sensitivity has decided that curing sick people simply reduces profits. Goldman Sachs, with a degree of insensitivity or perhaps just more grovelling to the rich, has come up with reasons for people to stay sick.
|
|
Digital transformation has affected many sectors of the economy, and this includes healthcare and related activities, such as new technologies. A new report signals some major changes coming for pharmaceuticals.
|
|
E-learning carries many advantages for companies, including delivering training remotely and with minimum disruption. One area of increased take-up is pharma. To understand how such training can be delivered, Laura Guardi of Pharmig explains.
|
Pharmaceutical companies are under pressure to reduce expenses while improving results. This is one reason why the sector is looking towards digital technologies. A company down this journey is life science business Merck & Co.
|
|
Berlin -
The impact and future of digitization along the value chain of the pharmaceutical industry have been discussed at a recent conference. The process of digital transformation presents both opportunities and threats for pharma.
|
|
Industry 4.0, especially the approaches of cyber-physical systems control and monitor activity through computer-based algorithms, are impacting on the bioprocessing sector as pharmaceuticals seek improved efficiencies.
|
|
Of the different sectors of the British economy affected by the U.K.’s impending exit from the European Union, the pharmaceutical sector is one of the most significant. This relates to the value of the market and the regulatory impact.
|
|
A new paradigm is taking place in the world of pharmaceuticals, with a shift away from re-used, re-washed and re-sterilized equipment and eastwards the adoption of single-use sterile systems.
|
|
New technologies, cloud computing, and wider use of risk assessment are among the continuing changes that are disrupting the pharmaceutical sector. Expect 2018 to see the pace of change to accelerate.
|
|
Oxford -
Pharmaceutical organizations need to embrace rapid methods in order to protect patients, obtain faster results, and help to address inventory issues. This was a key message delivered at the annual Pharmig conference.
|
|
Washington -
CaryRx is a pharmacy startup that has set out to rebuild the pharmacy concept from the ground up, through the use of a mobile app. To hear more about this next generation approach to pharmacies we spoke with company co-founder Areo Nazari.
|
|
Otocec -
Data integrity is necessary for ensuring the safety of medicine, helping to assure that release tests are correct and have not been corrupted. This was a key message at a recent Pharmig conference held in Slovenia.
|
|
Digital healthcare represents a fast-moving field. However, as a new survey indicates, job skills are creating unevenness within the field — and problems for the industry overall.
|
|
The next wave of digital health technology needs to focus on the patient experience, either in the way patients interact with technology or the way the use it. This is a key finding from a new report into the state of pharmaceuticals and healthcare.
|
|
The tenth PwC report into the ‘digital health IQ’ of looks at the state of companies operating in the pharmaceutical and life sciences sector and it shows a faster, although sometimes uneven, rate of adoption of healthcare technology.
|
|
London -
Searching for new types of drugs is a medical imperative. This is a complex task involving many types of diseases and chemical interactions. To assist with this process, Francis Crick Institute researchers have developed a new model.
|
|
When it comes to supply chain practices, pharmaceuticals must address the normal concerns of customer satisfaction and the control goods as well as strict regulatory requirements. To better produce medicines, a new high-tech sensor has been developed.
|
|
Pharmaceutical companies are showing an increased interest in big data, focused on areas like drug discovery and with a realization this can give them a competitive advantage. This might not come so easily, however, without a joined-up strategy.
|
|
Pharmaceutical organizations are increasingly reliant upon automated systems and computers, from manufacturing to laboratory release testing. This has brought a renewed regulatory focus on the subject of data integrity.
|
|
Washington -
The company Quascenta has simplified cleaning validation for active pharmaceutical ingredient manufacturers through a new software package called eResidue. Cleaning validation is a key process, and it avoids cross-contamination.
|
apis-378939 apis-377176 apis-375741 apis-375729 apis-370058 apis-369691 apis-369420 apis-367544 apis-364221 apis-363635 apis-363064 apis-362058 apis-361780 apis-361032 apis-358756 apis-354313 apis-353837 apis-352024 apis-350629 apis-348871 apis-346127 apis-346123 apis-346122 apis-342725 apis-342596 apis-340359 apis-340356 apis-340152
Pharmaceuticals Image
U.S. drug company sues Canada for trying to lower cost of $700K-a-year drug Alexion Pharmaceuticals
Medicine vials on display at making Pharmaceuticals 2015.
Sativex contains marijuana-derived ingredients. Associated Press
Biogen is an American global biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide. Biogen
Project Team at work: Expertise helps AbbVie develop and enhance products and therapies to treat conditions including HIV, arthritis, immunological and metabolic disorders, heart disease, and cancer. © AbbVie Inc.
Pharmaceutical manufacturing at BPL, Elstree, UK.
Eli Lilly's global headquarters, Indianapolis, Indiana Guanaco152003
|
|
